Tianeptine, a atypical antidepressant, operates through a novel mechanism compared to conventional antidepressants, primarily impacting the alteration of serotonin pathways . Initially introduced in France , it’s increasingly utilized for conditions it wasn't initially approved for to treat mood disorders, particularly when conventional treatment